European Union
In force Implementing regulation 23 units
Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011eu-implementing-regulation-2024-03-08-821Mar 8, 2024
- Preamble 1
- recital 1 recital 1
- recital 2 recital 2
- recital 3 recital 3
- recital 4 recital 4
- recital 5 recital 5
- recital 6 recital 6
- recital 7 recital 7
- recital 8 recital 8
- recital 9 recital 9
- recital 10 recital 10
- recital 11 recital 11
- recital 12 recital 12
- recital 13 recital 13
- recital 14 recital 14
- recital 15 recital 15
- recital 16 recital 16
- recital 17 recital 17
- Article 1 Renewal of the approval of the active substance
- Article 2 Amendments to Implementing Regulation (EU) No 540/2011
- Article 3 Entry into force and date of application
- Annex I ANNEX I
- Annex II ANNEX II